Comparative Effectiveness Feasibility Trial for Insomnia Among Breast Cancer Survivors

Comparative Effectiveness Feasibility Trial for Insomnia Among Breast Cancer Survivors

Women with breast cancer who report insomnia that started or worsened during breast cancer diagnosis and treatment will be enrolled in a group behavioral trial to one of two arms testing cognitive behavioral therapy for insomnia against a mindfulness-based therapy.

The investigators are recruiting breast cancer survivors with stage I-III or Eastern Cooperative Oncology Group 0-1 breast cancer to enroll in a group-delivered behavioral trial for insomnia. The investigators are comparing mindfulness-based therapies delivered in an alternative medicine context to cognitive behavioral therapy for insomnia. The intervention is 9 weeks, for two hours weekly.

Inclusion Criteria:

• American Joint Committee on Cancer (AJCC) Stage I-III or Eastern Cooperative Oncology Group (ECOG) 0-1 breast cancer
• completed active treatment (surgery, radiation, chemotherapy) at least three months prior
• within 5 years of treatment or still on adjuvant therapy
• Completes informed consent to participate

Exclusion Criteria:

• sleep apnea or restless leg syndrome
• practicing mindfulness techniques >1/wk